March 25, 2003 - Volume 25 - Issue 6
pp: 4-44

PDF Only



Ovarian Cancer: Adjuvant Chemo Reduces Recurrence, But So Does Adequate Staging

Carlson, Robert H.

Oncology Times . 25(6):5-7, March 25, 2003.

The standard of care for high-risk early ovarian cancer is adjuvant chemotherapy after surgery, but the big question is which patients are at high risk, something that is not always obvious. The large ACTION and ICON1 European Phase III studies have now been reported, but the question remains open.

Liability Reform Legislation is Back. Sen. Grassley Promises This Time It Will Win Passage in Senate

Eastman, Peggy

Oncology Times . 25(6):11-14, March 25, 2003.

The Chairman of the Senate Finance Committee, also a member of the Senate Judiciary Committee, has pledged to do all he can to pass medical malpractice reform. “Our situation is so bad I'll vote for broad tort reform, weak tort reform, whatever we can get passed,” he says.



Colorectal Cancer: Tailored Approaches with PCR Analysis Promise Better Outcomes

Goodman, Alice

Oncology Times . 25(6):16-18,23, March 25, 2003.

Research discoveries are paving the way for customized chemotherapy for colorectal cancer, entailing individualized therapy based on molecular knowledge about the patient's tumor as well as normal tissue. Evidence for inter-individual differences is illustrated by differences in response to 5-FU, as well as newer drugs.